Revision Therapeutics, Inc.
Get Full AccessDescription
- ReVision Therapeutics is an ophthalmic biopharmaceutical company developing a novel, small-molecule drug for the treatment and prevention of dry age-related macular degeneration.
-
Headquarters:5626 Oberlin Dr Ste 100 , San Diego, California, United States
More -
Phone Number: +1 858-348-2180
-
Website: https://www.revisiontherapeutics.com
-
Employees:0
-
Revenue:$0 - 1M
-
Legal Name:Revision Therapeutics, Inc.
-
Revision Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Revision Therapeutics, Inc.
-
Where are Revision Therapeutics, Inc.'s Headquarters?
Revision Therapeutics, Inc.'s Headquarters are in 5626 Oberlin Dr Ste 100 ,San Diego,California,United States
-
What is Revision Therapeutics, Inc.'s phone number?
Revision Therapeutics, Inc.'s phone number is +1 858-348-2180
-
What is Revision Therapeutics, Inc.'s official website?
Revision Therapeutics, Inc.'s official website is https://www.revisiontherapeutics.com
-
What is Revision Therapeutics, Inc.'s Revenue?
Revision Therapeutics, Inc.'s revenue is $0 - 1M
-
What is Revision Therapeutics, Inc.'s NAICS code?
Revision Therapeutics, Inc.'s NAICS code is 325412
-
What is Revision Therapeutics, Inc.'s Industry?
Revision Therapeutics, Inc. is in the industry of Pharmaceuticals
-
Who is Revision Therapeutics, Inc.'s Chief Scientific Officer?
Revision Therapeutics, Inc.'s Chief Scientific Officer is Nathan Mata

